These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 21134422)
21. Modulation of hippocampus-prefrontal cortex synaptic transmission and disruption of executive cognitive functions by MK-801. Blot K; Kimura S; Bai J; Kemp A; Manahan-Vaughan D; Giros B; Tzavara E; Otani S Cereb Cortex; 2015 May; 25(5):1348-61. PubMed ID: 24304584 [TBL] [Abstract][Full Text] [Related]
22. Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 mice. Wiebelhaus JM; Vunck SA; Meltzer HY; Porter JH Behav Pharmacol; 2012 Jun; 23(3):262-70. PubMed ID: 22547022 [TBL] [Abstract][Full Text] [Related]
23. Adjunctive clozapine with bright light mitigates cognitive deficits by synaptic plasticity and neurogenesis in sub-chronic MK-801 treated mice. Zhang L; Zhou Y; Xie Y; Ying Y; Li Y; Ye S; Wang Z Pharmacol Biochem Behav; 2024 Oct; 243():173821. PubMed ID: 39002805 [TBL] [Abstract][Full Text] [Related]
24. Neuroprotective effects of MK-801 against traumatic brain injury in immature rats. Sönmez A; Sayın O; Gürgen SG; Çalişir M Neurosci Lett; 2015 Jun; 597():137-42. PubMed ID: 25943283 [TBL] [Abstract][Full Text] [Related]
25. Effects of the cognition impairer MK-801 on learning and memory in mice and rats. van der Staay FJ; Rutten K; Erb C; Blokland A Behav Brain Res; 2011 Jun; 220(1):215-29. PubMed ID: 21310186 [TBL] [Abstract][Full Text] [Related]
26. α7 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats. Unal G; Sirvanci S; Aricioglu F Behav Brain Res; 2021 Jan; 397():112946. PubMed ID: 33011186 [TBL] [Abstract][Full Text] [Related]
27. Pro-cognitive action of CART is mediated via ERK in the hippocampus. Bharne AP; Borkar CD; Bodakuntla S; Lahiri M; Subhedar NK; Kokare DM Hippocampus; 2016 Oct; 26(10):1313-27. PubMed ID: 27258934 [TBL] [Abstract][Full Text] [Related]
28. Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats. Rezvani AH; Kholdebarin E; Dawson E; Levin ED Int J Neuropsychopharmacol; 2008 Feb; 11(1):63-70. PubMed ID: 17295931 [TBL] [Abstract][Full Text] [Related]
29. The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine. Weiner DM; Meltzer HY; Veinbergs I; Donohue EM; Spalding TA; Smith TT; Mohell N; Harvey SC; Lameh J; Nash N; Vanover KE; Olsson R; Jayathilake K; Lee M; Levey AI; Hacksell U; Burstein ES; Davis RE; Brann MR Psychopharmacology (Berl); 2004 Dec; 177(1-2):207-16. PubMed ID: 15258717 [TBL] [Abstract][Full Text] [Related]
30. N-desmethylclozapine: is there evidence for its antipsychotic potential? Mendoza MC; Lindenmayer JP Clin Neuropharmacol; 2009; 32(3):154-7. PubMed ID: 19483482 [TBL] [Abstract][Full Text] [Related]
31. Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients. Molins C; Carceller-Sindreu M; Navarro H; Carmona C; Piñeiro M; Martínez E; Álvarez E; Portella MJ Psychiatry Res; 2017 Dec; 258():153-157. PubMed ID: 29024893 [TBL] [Abstract][Full Text] [Related]
32. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions. Arif M; Chikuma T; Ahmed MM; Yoshida S; Kato T Neurosci Res; 2007 Feb; 57(2):248-58. PubMed ID: 17141345 [TBL] [Abstract][Full Text] [Related]
33. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol. Gomes FV; Llorente R; Del Bel EA; Viveros MP; López-Gallardo M; Guimarães FS Schizophr Res; 2015 May; 164(1-3):155-63. PubMed ID: 25680767 [TBL] [Abstract][Full Text] [Related]
34. N-Desmethylclozapine, a major clozapine metabolite, acts as a selective and efficacious delta-opioid agonist at recombinant and native receptors. Onali P; Olianas MC Neuropsychopharmacology; 2007 Apr; 32(4):773-85. PubMed ID: 16841075 [TBL] [Abstract][Full Text] [Related]
35. Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action. Zhou X; Cai G; Mao S; Xu D; Xu X; Zhang R; Yao Z BMC Psychiatry; 2020 Mar; 20(1):106. PubMed ID: 32143671 [TBL] [Abstract][Full Text] [Related]
36. Effects of olanzapine and clozapine on radial maze performance in naive and MK-801-treated mice. Mutlu O; Celikyurt IK; Ulak G; Tanyeri P; Akar FY; Erden F Arzneimittelforschung; 2012 Jan; 62(1):4-8. PubMed ID: 22331755 [TBL] [Abstract][Full Text] [Related]
37. The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors. Heusler P; Bruins Slot L; Tourette A; Tardif S; Cussac D Eur J Pharmacol; 2011 Nov; 669(1-3):51-8. PubMed ID: 21835172 [TBL] [Abstract][Full Text] [Related]
38. Glycinamide prevents MK-801-induced hyperactivity and deficits in object recognition memory in an animal model of positive and cognitive symptoms of schizophrenia. Basurto E; Flores OG; Hoffman KL Schizophr Res; 2015 Aug; 166(1-3):349-50. PubMed ID: 25823398 [No Abstract] [Full Text] [Related]
39. The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats. Prus AJ; Pehrson AL; Philibin SD; Wood JT; Vunck SA; Porter JH Psychopharmacology (Berl); 2009 Apr; 203(2):295-301. PubMed ID: 18685832 [TBL] [Abstract][Full Text] [Related]
40. Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine. Zuo DY; Cao Y; Zhang L; Wang HF; Wu YL Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):290-5. PubMed ID: 19121361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]